Combining hypoxia-activated prodrugs and radiotherapy in silico : Impact of treatment scheduling and the intra-tumoural oxygen landscape (2019)
Attributed to:
Developing new paradigms for overcoming drug resistance in cancer using novel humanised mouse models
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/856443
Publication URI: http://dx.doi.org/10.1101/856443
Type: Preprint